Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2024

Mar 8, 2024

3695_dirs_2024-03-08_3df88482-98d2-4f98-a3a8-859811641f6d.html

Director's Dealing

Open in viewer

Opens in your device viewer

Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider

Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider

Oslo, Norway, March 8, 2024 - Primary insider Bernd R. Seizinger, Member of the Board of Directors of Nykode Therapeutics ASA, has today acquired 25,000 shares in Nykode Therapeutics ASA at an average price of NOK 14.81 per share. Following the transaction, Bernd R. Seizinger holds 625,000 shares in Nykode Therapeutics ASA.

Please see further details in the attached document.